You just read:

Janssen to Present Latest Research from Robust Blood Cancer and Cardiovascular Disease Portfolios at this Year's American Society of Hematology Annual Meeting

News provided by

The Janssen Pharmaceutical Companies of Johnson & Johnson

Nov 06, 2019, 09:54 ET